Brief: Lipella Pharmaceuticals Got Notice Of Delisting From Nasdaq
23/08/2024 23:22
Aug 23 (Reuters) - Lipella Pharmaceuticals Inc LIPO.O :
* LIPELLA PHARMACEUTICALS INC: GOT NOTICE OF DELISTING OR
FAILURE
TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Further company coverage: LIPO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lipella Pharmaceuticals
See all newsBrief: Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4
Brief: Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11
Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group